Projects per year
Fingerprint
Dive into the research topics where Alex Adjei is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Finished
-
Experimental Therapeutics Program
Adjei, A. & Kaufmann, S. S. H.
3/1/19 → 2/29/24
Project: Research project
-
Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.
Levine, E. G., Adjei, A., Ernstoff, M. S., Lele, S. & Singh, A. K.
5/6/14 → 2/28/19
Project: Research project
-
NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis
Adjei, A., Erlichman, C., Haluska, P. R. J. & Ramanathan, R. K.
4/7/14 → 2/28/21
Project: Research project
-
A challenging case of stage IV EGFR-mutant lung cancer with histologic transformation and multiple resistance mechanisms
Rivera-Concepcion, J., Lo, Y. C., Uprety, D., Adjei, A. A., Ernani, V. & Leventakos, K., Mar 2024, In: Current Problems in Cancer: Case Reports. 13, 100284.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors
Janku, F., Choong, G. M., Opyrchal, M., Dowlati, A., Hierro, C., Rodon, J., Wicki, A., Forster, M. D., Blagden, S. P., Yin, J., Reid, J. M., Muller, H., Cmiljanovic, N., Cmiljanovic, V. & Adjei, A. A., Mar 2024, In: Cancers. 16, 6, 1137.Research output: Contribution to journal › Article › peer-review
Open Access -
Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study
Vokes, E. E., Mornex, F., Sezer, A., Cheng, Y., Fang, J., Baz, D. V., Cil, T., Adjei, A. A., Ahn, M. J., Barlesi, F., Felip, E., Garon, E. B., Audhuy, F., Ito, R., Sato, M., Eggleton, S. P., Martin, C. M., Reck, M., Robinson, C. G. & Paz-Ares, L., Feb 2024, In: Journal of Thoracic Oncology. 19, 2, p. 285-296 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort
Emiloju, O. E., Yin, J., Koubek, E., Reid, J. M., Borad, M. J., Lou, Y., Seetharam, M., Edelman, M. J., Sausville, E. A., Jiang, Y., Kaseb, A. O., Posey, J. A., Davis, S. L., Gores, G. J., Roberts, L. R., Takebe, N., Schwartz, G. K., Hendrickson, A. E. W., Kaufmann, S. H., Adjei, A. A., & 2 others , Feb 2024, In: Investigational New Drugs. 42, 1, p. 127-135 9 p.Research output: Contribution to journal › Article › peer-review
-
A Clinician's Guide to Bioinformatics for Next-Generation Sequencing
Larson, N. B., Oberg, A. L., Adjei, A. A. & Wang, L., Feb 2023, In: Journal of Thoracic Oncology. 18, 2, p. 143-157 15 p.Research output: Contribution to journal › Review article › peer-review
Open Access